|M10777||AGN 194310||AGN 194310 (VTP-194310) is a highly affinity, potent, selective pan antagonist of retinoic acid receptors (RARs) against RARα, RARβ, RARγ Kd The values are 3 nM, 2 nM, and 5 nM, respectively.|
|M10238||PAR-2 (6-1) amide (human)||VKGILS-NH2 is a reversed amino acid sequence control peptide for SLIGKV-NH2.|
|M10237||Protease-Activated Receptor-2, amide||Protease-Activated Receptor-2, amide (SLIGKV-NH2) is a highly potent agonist of PAR2 with IC50 of 10.4 uM.|
|M10236||PAR-2 (1-6) (mouse, rat)||PAR-2 (1-6) (mouse, rat) is a PAR2 activator, it can be used to explore signaling through PAR2 in cells.|
|M10235||SLIGRL-NH2||SLIGRL-NH2 (Protease-Activated Receptor-2 Activating Peptide) is an agonist of Protease-Activated Receptor-2 (PAR-2).|
|M10143||AZ3451||AZ3451 is a potent PAR2 (protease-activated receptor-2) antagonist with IC50 of 23 nM, which plays a part in inflammation response, apoptosis, autophagy and cellular senescence during Osteoarthritis (OA).|
|M9814||(Ala1)-PAR-4 (1-6) (mouse)||(Ala1)-PAR-4 (1-6) (mouse)|
|M9813||PAR-4 (1-6) (mouse)||PAR-4 (1-6) (mouse)|
|M9812||PAR-4 (1-6) (human)||PAR-4 (1-6) (human) is an N-terminal fragment of protease-activated receptor 4 (PAR4) that acts as a PAR4 agonist.|
|M6243||Vorapaxar Sulfate||Vorapaxar is a first-in-class, potent and orally-active protease-activated receptor 1 (PAR-1) antagonist that blocks thrombin-mediated platelet activation without interfering with thrombin-mediated fibrin deposition.|
|M3123||Vorapaxar||Vorapaxar (SCH 530348) is a potent and orally active thrombin receptor (PAR-1) antagonist with Ki of 8.1 nM.|
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2020 AbMole BioScience. All Rights Reserved.